Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action

Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types — neutrophils and antigen-presenting cells — in samples from early-stage human lung cancers. This is the first study to describe this phenomenon in a human tumor.